Table 2 Global statistics on survival related variables for the datasets available in PROGmiR
Survival event | No event | ||||||
|---|---|---|---|---|---|---|---|
Cancer type | Dataset | Total no of samples | No of samples | Median survival§(range) | No of samples | Median survival§*(range) | |
1 | Adrenocortial Carcinoma | GSE22816 | 22 | 6 | 600 (120-4860) | 16 | 885 (60-4980) |
2 | Acute Myeloid Leukemia | LAML | 164 | 100 | 303 (28-1706) | 64 | 699 (28-2861) |
3 | Brain Lower Grade Glioma | LGG | 29 | 23 | 788 (96-1915) | 6 | 1317 (242-6423) |
4 | Glioblastoma multiforme | GBM | 487 | 383 | 377 (3-3880) | 104 | 266 (3-2817) |
5 | Breast Invasive Carcinoma | BRCA | 727 | 91 | 1563 (157-4456) | 636 | 466 (1-6795) |
6 | Non-small-cell Lung Cancer | GSE16025 | 60 | 26 | 1980 (210-2490) | 34 | 1500 (120-2580) |
7 | Small Cell Lung Cancer | GSE27435 | 42 | 18 | 743 (234-2400) | 24 | 1314 (426 -2490) |
8 | Lung Adenocarcinoma | LUAD | 79 | 27 | 701 (22-1318) | 52 | 400 (1-2161) |
9 | Lung Squamous Cell Carcinoma | LUSC | 185 | 77 | 544 (12-5296) | 108 | 640 (3-4299) |
10 | Hepatocellular Carcinoma | GSE31384 | 166 | 73 | 450 (30 – 2280) | 93 | 1320 (420-2430) |
11 | Head and Neck Squamous Cell Carcinoma | HNSC | 89 | 27 | 395 (128 – 2318) | 62 | 359 (45 – 4115) |
12 | Ovarian Cystadenocarcinoma | OV | 46 | 21 | 887 (9-1756) | 25 | 912 (141 – 2099) |
13 | Rectal Adenocarcinoma | READ | 38 | 3 | 316 (59 – 1184) | 35 | 183 (28 – 2192) |
14 | Renal Clear Cell Carcinoma | KIRC | 546 | 173 | 722 (2-2830) | 373 | 1307 (4 – 3377) |
15 | Stomach Adenocarcinoma | STAD | 79 | 14 | 258 (19 – 881) | 65 | 109 (2 – 2131) |
16 | Uterine Corpus Endometroid Carcinoma | UCEC | 358 | 27 | 413 (58 – 3251) | 331 | 527 (1 – 5690) |